Status:
ENROLLING_BY_INVITATION
The Effect of an Individual Empowerment Program Provided to Relatives of Schizophrenia Patients
Lead Sponsor:
Istanbul Arel University
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Psychoeducation provided to family members caring for individuals with schizophrenia. Has been found to positively impact caregivers' psychological well-being and the effective management of schizophr...
Detailed Description
Schizophrenia is a chronic mental disorder characterized by psychotic experiences accompanied by language, thought, perception, and behavioral disorders, involving periods of relapse and remission (Zh...
Eligibility Criteria
Inclusion
- Being the primary caregiver of a patient diagnosed with schizophrenia and other psychotic disorders Volunteering to participate in the study Being 18 years of age or older Being literate Not having a psychiatric illness (diagnosis) Not having a serious mental or physical disorder that prevents communication
Exclusion
- Providing care to patients with severe organic brain syndrome such as alcohol or substance dependence, intellectual disability, dementia, or delirium, or with a previous or current general medical condition that could impair cognitive function Withdrawal from the study
Key Trial Info
Start Date :
May 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 15 2026
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT07173192
Start Date
May 15 2025
End Date
February 15 2026
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Arel University
Istanbul, Cevizlibağ, Turkey (Türkiye), 34010